Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2007;334:827 (21 April), doi:10.1136/bmj.39171.511794.AD
John Firth, consultant nephrologist
Addenbrooke's Hospital, Cambridge CB2 2QQ
jfirth@doctors.org.uk
No healthcare system can afford to pay for all available treatments. Robert Marcus believes doctors have a duty to tell patients about unfunded drugs, but John Firth argues that it will cause them harm
| The first 150 words of the full text of this article appear below. |
I am a kidney doctor. Mr Brown, a frail 79 year old man who lives in social housing, comes to my clinic. He has advanced chronic renal failure, cause unknown, but not so far advanced that dialysis would be likely to benefit him, and in previous discussion with me and the dialysis nurses he has said that he doesn't want it in the future anyway. He tells me that he is tired, has no energy, and getting around is more of an effort than it used to be, but he is eating satisfactorily and his diagnosis is that he thinks he's getting old. His haemoglobin is 101 g/l.
I suspect that he would feel better if his haemoglobin was higher. He is not iron deficient. Erythropoietin would be the most appropriate treatment on clinical grounds and likely to be successful. Such treatment agrees with the current guidance from National Institute
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
Read all Rapid Responses